Effect of the dialysis fluid buffer on peritoneal membrane function in children

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 1, 2013, Pages 108-115

  Schmitt, Claus Peter ^a   Nau, Barbara ^a   Gemulla, Gita ^a   Bonzel, Klaus E ^b   Hölttä, Tuula ^c   Testa, Sara ^d   Fischbach, Michel ^e   John, Ulrike ^f   Kemper, Markus J ^g   Sander, Anja ^h   Arbeiter, Klaus ⁱ   Schaefer, Franz ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^d University Children's Hospital   (Italy)

^e University Children's Hospital   (France)

^f JENA UNIVERSITY HOSPITAL   (Germany)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; BICARBONATE; BIOMATERIAL; C REACTIVE PROTEIN; CREATININE; GLUCOSE; GLUCOSE DEGRADATION PRODUCT; LACTIC ACID; PERITONEAL DIALYSIS FLUID;

ACID BASE BALANCE; ADOLESCENT; ADULT; ARTICLE; CHEMICAL ANALYSIS; CHILD; CHILD SAFETY; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MALE; METABOLIC ACIDOSIS; MULTICENTER STUDY; NEWBORN; PERITONEAL DIALYSIS; PERITONITIS; PH; PHOSPHATE METABOLISM; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; ULTRAFILTRATION; WATER TRANSPORT;

ACID-BASE EQUILIBRIUM; ACIDOSIS; ADOLESCENT; BICARBONATES; BODY WATER; BUFFERS; CHILD; CHILD, PRESCHOOL; DIALYSIS SOLUTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; LACTIC ACID; MALE; PERITONEAL DIALYSIS; PERITONEUM; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872198034     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00690112     Document Type: Article

References (42)

1. Jorres A, Bender TO, Finn A, Witowski J, Frohlich S, Gahl GM, Frei U, Keck H, Passlick-Deetjen J: Biocompatibility and buffers: Effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function. Kidney Int 54: 2184-2193, 1998
2. Witowski J, Korybalska K, Ksiazek K, Wisniewska-Elnur J, Jorres A, Lage C, Schaub TP, Passlick-Deetjen J, Breborowicz A, Grzegorzewska A, Ksiazek A, Liberek T, Lichodziejewska-Niemierko M, Majdan M, Rutkowski B, Stompór T, Sulowicz W: Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant 19: 917-924, 2004
3. Hekking LH, Zareie M, Driesprong BA, Faict D, Welten AG, de Greeuw I, Schadee-Eestermans IL, Havenith CE, van den Born J, ter Wee PM, Beelen RH: Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J Am Soc Nephrol 12: 2775-2786, 2001
4. Mortier S, Faict D, Lameire NH, De Vriese AS: Benefits of switching from a conventional to a low-GDP bicarbonate/lactatebuffered dialysis solution in a rat model. Kidney Int 67: 1559-1565, 2005
5. Wieczorowska-Tobis K, Brelinska R, Witowski J, Passlick-Deetjen J, Schaub TP, Schilling H, Breborowicz A: Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products. Perit Dial Int 24: 48-57, 2004
6. Kim SG, Kim S, Hwang YH, Kim K, Oh JE, Chung W, Oh KH, Kim HJ, Ahn C; Korean Balnet Study Group;: Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients? A 1-year multicenter prospective randomized controlled trial (Balnet Study). Perit Dial Int 28[Suppl 3]: S117-S122, 2008
7. Haag-Weber M, Kramer R, Haake R, Islam MS, Prischl F, Haug U, Nabut JL, Deppisch R; behalf of the DIUREST Study Group;: Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: A prospective randomized study. Nephrol Dial Transplant 25: 2288-2296, 2010
8. Choi HY, Kim DK, Lee TH, Moon SJ, Han SH, Lee JE, Kim BS, Park HC, Choi KH, Ha SK, Han DS, Lee HY: The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: An open randomized prospective trial. Perit Dial Int 28: 174-182, 2008
9. Zeier M, Schwenger V, Deppisch R, Haug U, Weigel K, Bahner U, Wanner C, Schneider H, Henle T, Ritz E: Glucose degradation products in PD fluids: Do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 63: 298-305, 2003
10. Schmitt CP, von Heyl D, Rieger S, Arbeiter K, Bonzel KE, Fischbach M, Misselwitz J, Pieper AK, Schaefer F; for the Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS);: Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content. Nephrol Dial Transplant 22: 2038-2044, 2007
11. Lee HY, Choi HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, Kim YH, Kim YL, Kim DJ, Kim YS, Kim MJ, Shin SK: Changing prescribing practice in CAPD patients in Korea: Increased utilization of low GDP solutions improves patient outcome. Nephrol Dial Transplant 21: 2893-2899, 2006
12. Han SH, Ahn SV, Yun JY, Tranaeus A, Han DS: Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions. Am J Kidney Dis 54: 711-720, 2009
13. Muller-Krebs S, Kihm LP, Zeier B, Gross ML, Deppisch R, Wieslander A, Henle T, Penndorf I, Oh J, Reiser J, Nawroth PP, Zeier M, Schwenger V: Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure. Eur J Clin Invest 38: 296-305, 2008
14. Topley N, Alobaidi HM, Davies M, Coles GA, Williams JD, Lloyd D: The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 34: 404-411, 1988
15. Topley N, Kaur D, Petersen MM, Jorres A, Williams JD, Faict D, Holmes CJ: In vitro effects of bicarbonate and bicarbonatelactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. J Am Soc Nephrol 7: 218-224, 1996
16. Plum J, Razeghi P, Lordnejad RM, Perniok A, Fleisch M, Fussholler A, Schneider M, Grabensee B: Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer-effects on human mesothelial cells. Am J Kidney Dis 38: 867-875, 2001
17. Ogata S, Naito T, Yorioka N, Kiribayashi K, Kuratsune M, Kohno N: Effect of lactate and bicarbonate on human peritoneal mesothelial cells, fibroblasts and vascular endothelial cells, and the role of basic fibroblast growth factor. Nephrol Dial Transplant 19: 2831-2837, 2004
18. Ogata S, Mori M, Tatsukawa Y, Kiribayashi K, Yorioka N: Expression of vascular endothelial growth factor, fibroblast growth factor, and lactate dehydrogenase by human peritoneal mesothelial cells in solutions with lactate or bicarbonate or both. Adv Perit Dial 22: 37-40, 2006
19. Albrektsson A, Bazargani F, Wieslander A, Braide M: Peritoneal dialysis fluid-induced angiogenesis in rat mesentery is increased by lactate in the presence or absence of glucose. ASAIO J 52: 276-281, 2006
20. Frischmann M, Spitzer J, Funfrocken M, Mittelmaier S, Deckert M, Fichert T, Pischetsrieder M: Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids. Biomed Chromatogr 23: 843-851, 2009
21. Erixon M, Wieslander A, Lindén T, Carlsson O, Forsback G, Svensson E, Jonsson JA, Kjellstrand P: How to avoid glucose degradation products in peritoneal dialysis fluids. Perit Dial Int 26: 490-497, 2006
22. Tranaeus A; The Bicarbonate/Lactate Study Group;: A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution-clinical benefits. Perit Dial Int 20: 516-523, 2000
23. Schmitt CP, Haraldsson B, Doetschmann R, Zimmering M, Greiner C, Boswald M, Klaus G, Passlick-Deetjen J, Schaefer F: Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children. Kidney Int 61: 1527-1536, 2002
24. Haas S, Schmitt CP, Arbeiter K, Bonzel KE, Fischbach M, John U, Pieper AK, Schaub TP, Passlick-Deetjen J, Mehls O, Schaefer F: Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis. J Am Soc Nephrol 14: 2632-2638, 2003
25. Montenegro J, Saracho RM, Martínez IM, Munoz RI, Ocharan JJ, Valladares E: Long-term clinical experience with pure bicarbonate peritoneal dialysis solutions. Perit Dial Int 26: 89-94, 2006
26. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, Passlick-Deetjen J; Euro Balance Trial Group;: The Euro-Balance Trial: The effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 66: 408-418, 2004
27. Simonsen O, Sterner G, Carlsson O, Wieslander A, Rippe B: Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered with bicarbonate/lactate mixture. Perit Dial Int 26: 353-359, 2006
28. Fischbach M, Stefanidis CJ, Watson AR; European Paediatric Peritoneal Dialysis Working Group;: Guidelines by an ad hoc European committee on adequacy of the paediatric peritoneal dialysis prescription. Nephrol Dial Transplant 17: 380-385, 2002
29. Schaefer F, Langenbeck D, Heckert K-H, Scharer K, Mehls O: Evaluation of peritoneal solute transfer by the peritoneal equilibration test in children. Adv Perit Dial 8: 410-415, 1992
30. Schaefer F, Klaus G, Muller-Wiefel DE, Mehls O; The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS);: Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. J Am Soc Nephrol 10: 136-145, 1999
31. Mortier S, De Vriese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH: Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol 13: 480-489, 2002
32. Kumar VB, Viji RI, Kiran MS, Sudhakaran PR: Endothelial cell response to lactate: Implication of PAR modification of VEGF. J Cell Physiol 211: 477-485, 2007
33. Végran F, Boidot R, Michiels C, Sonveaux P, Feron O: Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kB/IL-8 pathway that drives tumor angiogenesis. Cancer Res 71: 2550-2560, 2011
34. Walenta S, Mueller-Klieser WF: Lactate: Mirror and motor of tumor malignancy. Semin Radiat Oncol 14: 267-274, 2004
35. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, Mueller-Klieser W: Elevated tumor lactate concentrations predict for an increased risk of metastases in headand-neck cancer. Int J Radiat Oncol Biol Phys 51: 349-353, 2001
36. Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfør K, Rofstad EK, Mueller-Klieser W: High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 60: 916-921, 2000
37. Zhai Y, Bloch J, Homme M, Schaefer J, Hackert T, Philippin B, Schwenger V, Schaefer F, Schmitt CP: Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells. Pediatr Nephrol 27: 1165-1177, 2012
38. Raaijmakers R, Coester A, Smit W, Krediet RT, Schroder CH: Free water transport in children on peritoneal dialysis is higher with more biocompatible dialysis solutions, higher with older age and declines with time. Nephrol Dial Transplant 27: 1183-1190, 2012
39. Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F: Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16: 1494-1500, 2005
40. Schneble F, Bonzel KE, Waldherr R, Bachmann S, Roth H, Scharer K: Peritoneal morphology in children treated by continuous ambulatory peritoneal dialysis. Pediatr Nephrol 6: 542-546, 1992
41. Montenegro J, Saracho R, Gallardo I, Martínez I, Munoz R, Quintanilla N: Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis. Nephrol Dial Transplant 22: 1703-1708, 2007
42. Furkert J, Zeier M, Schwenger V: Effects of peritoneal dialysis solutions low in GDPs on peritonitis and exit-site infection rates. Perit Dial Int 28: 637-640, 2008